BSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News Details
Ajanta Pharma Ltd Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
532331
ISIN Demat
INE031B01049
Book Value (Rs)
338.0498657
NSE Symbol
AJANTPHARM
Divident Yield %
0.83
Market Cap
(Rs In Cr.)
42,202
P/E (TTM)
44.82
EPS (TTM)
75.36
Face Value
(Rs)
2
Back
Ajanta Pharma's Paithan unit concludes USFDA inspection
22-Apr-26   Hrs IST

Ajanta Pharma announced that the USFDA has concluded an inspection at its manufacturing facility at Paithan, in Maharashtra. The Inspection was conducted from 13 April 2026, to 21 April 2026, and closed with the issuance of Form-483 with 5 (five) observations.

Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, Developed and Maintained by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)